William George Ondo
#152,386
Most Influential Person Now
William George Ondo's AcademicInfluence.com Rankings
William George Ondophilosophy Degrees
Philosophy
#8479
World Rank
#11869
Historical Rank
Logic
#5507
World Rank
#6912
Historical Rank
Download Badge
Philosophy
Why Is William George Ondo Influential?
(Suggest an Edit or Addition)William George Ondo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. (2014) (1015)
- International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study (2006) (912)
- The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study (2007) (819)
- A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. (2016) (648)
- A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study. (2002) (547)
- Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. (2003) (538)
- Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome (2003) (514)
- Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients (2007) (511)
- Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology (2006) (496)
- Ambulatory monitoring of freezing of gait in Parkinson's disease (2008) (433)
- The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire (2010) (363)
- Exploring the relationship between Parkinson disease and restless legs syndrome. (2002) (354)
- Practice Parameter: Therapies for essential tremor (2005) (340)
- Long-term evaluation of deep brain stimulation of the thalamus. (2006) (329)
- Complete genomic screen in Parkinson disease: evidence for multiple genes. (2001) (302)
- A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. (2014) (294)
- Deep brain stimulation: Preoperative issues (2006) (278)
- Clinical correlates of 6‐hydroxydopamine injections into A11 dopaminergic neurons in rats: A possible model for restless legs syndrome? (2000) (277)
- Restless legs syndrome (1996) (268)
- Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor (1998) (263)
- Double‐blind, placebo‐controlled, unforced titration parallel trial of quetiapine for dopaminergic‐induced hallucinations in Parkinson's disease (2005) (261)
- Modafinil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled parallel trial (2005) (251)
- Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12‐week, double‐blind, randomized, parallel‐group, placebo‐controlled study (2004) (240)
- A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease (2004) (231)
- Assessment of interrater and intrarater reliability of the Fahn–Tolosa–Marin Tremor Rating Scale in essential tremor (2007) (229)
- Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. (2007) (218)
- Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. (2016) (217)
- Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease (2003) (212)
- Pallidotomy for generalized dystonia (1998) (207)
- Predictors of impulsivity and reward seeking behavior with dopamine agonists. (2008) (204)
- Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. (2004) (195)
- Long-term monitoring of gait in Parkinson's disease. (2007) (193)
- Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. (2001) (190)
- Restless legs syndrome in monozygotic twins: Clinical correlates (2000) (189)
- Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1 (2011) (172)
- Daytime sleepiness and other sleep disorders in Parkinson’s disease (2001) (170)
- Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. (2018) (168)
- Olanzapine treatment for dopaminergic‐induced hallucinations (2002) (163)
- Practice guideline summary: Treatment of restless legs syndrome in adults (2016) (160)
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial (2013) (156)
- Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis (2017) (156)
- Re-emergent tremor of Parkinson’s disease (1999) (150)
- Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. (2012) (149)
- Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial (2011) (144)
- Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. (1999) (140)
- Methadone for refractory restless legs syndrome (2005) (136)
- Reliability of a new scale for essential tremor (2012) (136)
- Thalamic deep brain stimulation: comparison between unilateral and bilateral placement. (2001) (132)
- Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease (2009) (132)
- Projections of diencephalic dopamine neurons into the spinal cord in mice (2005) (131)
- Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. (2013) (130)
- Topiramate in essential tremor (2006) (129)
- Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. (2011) (125)
- Gabapentin for essential tremor: A multiple‐dose, double‐blind, placebo‐controlled trial (2000) (125)
- Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease (2006) (123)
- Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. (2017) (121)
- Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. (2008) (119)
- Ropinirole for restless legs syndrome (1999) (118)
- Rotigotine improves restless legs syndrome: A 6‐month randomized, double‐blind, placebo‐controlled trial in the United States (2010) (112)
- Spinal cord dopamine receptor expression and function in mice with 6‐OHDA lesion of the A11 nucleus and dietary iron deprivation (2007) (106)
- Locomotion Is Increased in A11-Lesioned Mice With Iron Deprivation: A Possible Animal Model for Restless Legs Syndrome (2007) (105)
- Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. (2010) (105)
- Long-term treatment of restless legs syndrome with dopamine agonists. (2004) (103)
- Benefits and Risks of Pharmacological Treatments for Essential Tremor (2003) (99)
- Basal Ganglia Neuronal Discharge in Primary and Secondary Dystonia in Patients Undergoing Pallidotomy (2003) (99)
- Comparison of Thalamotomy and Pallidotomy for the Treatment of Dystonia (2001) (96)
- Does the endogenous opiate system play a role in the Restless Legs Syndrome?: A pilot post-mortem study (2009) (94)
- Randomized controlled trial of deutetrabenazine for tardive dyskinesia (2017) (92)
- Assessment of motor function after stereotactic pallidotomy (1998) (87)
- A pilot study of the clinical efficacy and safety of memantine for Huntington's disease. (2007) (85)
- Tetrabenazine Treatment for Huntington's Disease-Associated Chorea (2002) (82)
- Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. (2008) (81)
- Concepts and Methods in Chronic Thalamic Stimulation for Treatment of Tremor: Technique and Application (2001) (72)
- Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population. (2011) (72)
- Encouraging initial response of restless legs syndrome to pramipexole (1998) (72)
- The North American Survey of Placement and Adjustment Strategies for Deep Brain Stimulation (2005) (68)
- Intravenous iron dextran for severe refractory restless legs syndrome. (2010) (62)
- Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls. (2000) (62)
- Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. (2003) (62)
- Psychiatric associations of adult-onset focal dystonia phenotypes (2017) (60)
- A Study of Chorea After Tetrabenazine Withdrawal in Patients With Huntington Disease (2008) (60)
- Predictors of battery life for the Activa Soletra 7426 Neurostimulator. (2007) (60)
- Brain magnetic resonance imaging (MRI) in parkinsonian disorders. (2009) (59)
- Restless Legs Syndrome: clinical features, diagnosis and a practical approach to management (2017) (59)
- Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial (2009) (58)
- Essential tremor-plus: a controversial new concept (2019) (58)
- Potential outcome measures and trial design issues for multiple system atrophy (2007) (58)
- Association between restless legs syndrome and essential tremor (2006) (57)
- Olfaction testing in patients with tremor‐dominant Parkinson's disease: Is this a distinct condition? (2005) (56)
- Clinical characteristics of pramipexole-induced peripheral edema. (2000) (55)
- Bruxism in Huntington's disease (2000) (53)
- Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial. (2011) (52)
- Orthostatic tremor: a review of 45 cases. (2014) (52)
- Tetrabenazine for hyperglycemic‐induced hemichorea–hemiballismus (2006) (51)
- Restless Legs Syndrome (2010) (50)
- Family‐based and population‐based association studies validate PTPRD as a risk factor for restless legs syndrome (2011) (49)
- Animal models of restless legs syndrome. (2007) (49)
- Restless legs syndrome: clinical features and treatment. (2000) (49)
- Onabotulinum toxin-A injections for sleep bruxism (2018) (47)
- Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease (2016) (47)
- Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations. (2006) (46)
- Vascular parkinsonism: Clinical correlates predicting motor improvement after lumbar puncture (2002) (46)
- Intrathecal baclofen for dystonia (2001) (46)
- Rheumatologic serologies in secondary restless legs syndrome (2000) (44)
- Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): [RETIRED] (2006) (44)
- Zonisamide for Essential Tremor (2007) (42)
- The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome (2018) (42)
- Knowledge gaps and research recommendations for essential tremor. (2016) (41)
- Role of Apomorphine in the Treatment of Parkinson’s Disease (2015) (41)
- Comparison of Weight Gain in Treatments for Tourette Syndrome: Tetrabenazine Versus Neuroleptic Drugs (2008) (38)
- Withdrawal of visual feedback improves micrographia in Parkinson's disease (2007) (38)
- Restless Legs Syndrome: Pathophysiology and Treatment (2014) (37)
- Comparison of the Fahn‐Tolosa‐Marin Clinical Rating Scale and the Essential Tremor Rating Assessment Scale (2018) (37)
- Open-Label Study Assessment of Safety and Adverse Effects of Subcutaneous Apomorphine Injections in Treating "Off" Episodes in Advanced Parkinson Disease (2009) (36)
- Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease. (1999) (36)
- Selegiline Orally Disintegrating Tablets in Patients With Parkinson Disease and "Wearing Off" Symptoms (2007) (35)
- G2019S mutation in the leucine‐rich repeat kinase 2 gene is not associated with multiple system atrophy (2007) (34)
- Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder (2017) (34)
- Lingual dystonia following electrical injury (1997) (34)
- Switching from pergolide to pramipexole in patients with Parkinson's disease (2001) (34)
- Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia (2019) (33)
- A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease (1999) (32)
- Computerized posturography balance assessment of patients with bilateral ventralis intermedius nuclei deep brain stimulation (2006) (32)
- Hyperglycemic nonketotic states and other metabolic imbalances. (2011) (32)
- An Open-Label Pilot Study of Levetiracetam for Essential Tremor (2004) (31)
- Clinical and demographic characteristics related to onset site and spread of cervical dystonia (2016) (30)
- Long-Term Efficacy of Rasagiline in Early Parkinson's Disease (2010) (30)
- Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States (2010) (30)
- Thalamic deep brain stimulation: Effects on the nontarget limbs (2001) (30)
- The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model. (2011) (29)
- Locomotor response to levodopa in fluctuating Parkinson’s disease (2008) (29)
- The α-synuclein gene is not a major risk factor in familial Parkinson disease (1999) (29)
- Flumazenil, a GABA antagonist, may improve features of Parkinson's disease (2003) (28)
- The Management of Restless Legs Syndrome: An Updated Algorithm. (2021) (28)
- Essential tremor: Treatment options (2006) (27)
- Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults (2020) (26)
- Evaluating factors that can influence spirography ratings in patients with essential tremor. (2005) (26)
- Sleep/wake problems in Parkinson’s disease: pathophysiology and clinicopathologic correlations (2014) (25)
- Essential Tremor: What We Can Learn from Current Pharmacotherapy (2016) (25)
- Treatment of fragile X associated tremor/ataxia syndrome with deep brain stimulation (2009) (25)
- Motor Complications in Parkinson's Disease (2011) (25)
- The Impact of DaTscan in the Diagnosis of Parkinson Disease (2015) (25)
- Subthalamic deep brain stimulation in patients with a previous pallidotomy (2006) (24)
- VIM deep brain stimulation does not improve pre-existing restless legs syndrome in patients with essential tremor. (2006) (24)
- Dystonia & tremor: A cross-sectional study of the dystonia coalition cohort. (2020) (23)
- Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registry (2017) (23)
- Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor (2020) (23)
- Current and Emerging Treatments of Essential Tremor. (2020) (22)
- Habituation and rebound to thalamic deep brain stimulation in long-term management of tremor associated with demyelinating neuropathy (2014) (22)
- Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome. (2012) (22)
- Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome (2015) (22)
- The use of gabapentin enacarbil in the treatment of restless legs syndrome (2010) (21)
- A Pilot Study of Botulinum Toxin A for Headache in Cervical Dystonia (2005) (20)
- Restless legs syndrome (2005) (20)
- Task-specific focal hand dystonia in a professional pistol-shooter (2008) (20)
- Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single‐dose, double‐blind, double‐dummy, placebo‐controlled, crossover trial (2010) (19)
- Apomorphine injections: predictors of initial common adverse events and long term tolerability. (2012) (19)
- Thalamic Deep Brain Stimulation for Orthostatic Tremor (2011) (19)
- Physiological assessment of paroxysmal dystonia secondary to subacute sclerosing panencephalitis (2002) (19)
- OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: A Systematic Literature Review (2015) (18)
- Correlates of Nonanemic Iron Deficiency in Restless Legs Syndrome (2020) (17)
- Pharmacological Management of Essential Tremor (2010) (17)
- Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson’s disease (2003) (17)
- The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. (1999) (17)
- Tetrabenazine treatment for stereotypies and tics associated with dementia. (2012) (16)
- Task-Specific Writing Tremor: Clinical Phenotypes, Progression, Treatment Outcomes, and Proposed Nomenclature (2012) (16)
- Consensus Guidelines on Rodent Models of Restless Legs Syndrome (2020) (15)
- Exome sequencing in familial corticobasal degeneration. (2013) (15)
- Vagus nerve stimulation for essential tremor (2003) (15)
- Optimizing extended-release carbidopa/levodopa in Parkinson disease (2017) (14)
- Common comorbidities and differential diagnosis of restless legs syndrome. (2014) (14)
- Restless legs syndrome in end stage renal disease patients undergoing hemodialysis (2019) (13)
- A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia (2018) (13)
- Predictors of placebo response in restless legs syndrome studies (2013) (13)
- Clinical features and subtypes of restless legs syndrome in Chinese population: a study of 359 patients. (2019) (13)
- Alcohol dehydrogenase polymorphism and Parkinson's disease (2001) (13)
- When to worry about headache. (1995) (13)
- Restless legs syndrome. (2005) (13)
- Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2 p 14 and 16 q 12 . 1 (2017) (13)
- Complete genomic screen in Parkinson Disease (2001) (12)
- Animal studies in restless legs syndrome (2007) (12)
- Depth and Distribution of Symptoms in Restless Legs Syndrome/ Willis-Ekbom Disease. (2016) (12)
- Resolution of Severe Obsessive–Compulsive Disorder After a Small Unilateral Nondominant Frontoparietal Infarct (2011) (11)
- A pilot study: Microlesion effects and tremor outcome in the ventrointermediate deep brain stimulation (VIM-DBS) (2010) (11)
- Restless legs syndrome / Willis – Ekbom disease diagnostic criteria : updated International Restless Legs (2014) (11)
- Does idiopathic restless legs syndrome delay onset and reduce severity of Parkinson's disease: a pilot study (2015) (11)
- We need to do better: A systematic review and meta-analysis of diagnostic test accuracy of restless legs syndrome screening instruments. (2021) (11)
- Systematic Literature Review of Quetiapine for the Treatment of Psychosis in Patients With Parkinsonism. (2019) (11)
- Restless legs syndrome secondary to pontine infarction: Clinical analysis of five cases (2017) (11)
- Restless Legs Syndrome "Patient Odyssey" survey of disease burden on patient and spouses/partners. (2017) (10)
- Effects of deep brain stimulation in relatively young-onset multiple system atrophy Parkinsonism (2014) (10)
- Handbook of Movement Disorders (2011) (10)
- Differentiating nocturnal leg cramps and restless legs syndrome (2014) (10)
- Intravenous flumazenil for Parkinson's disease: A single dose, double blind, placebo controlled, cross‐over trial (2006) (9)
- Dandy-Walker syndrome presenting as opisthotonus: proposed pathophysiology. (1996) (9)
- Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor (2020) (9)
- Correction: Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1 (2011) (9)
- Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's disease. (2011) (9)
- Clinical and radiological characteristics of restless legs syndrome following acute lacunar infarction. (2019) (9)
- Other movement disorders (2010) (9)
- PALLIDOTOMY AND GENERALIZED DYSTONIA. AUTHORS' REPLY (1999) (9)
- Epidemiology of restless legs syndrome. (2002) (8)
- Treating Hallucinations and Delusions Associated With Parkinson’s Disease Psychosis (2018) (8)
- A Phase 2 Proof‐of‐Concept, Randomized, Placebo‐Controlled Trial of CX‐8998 in Essential Tremor (2021) (8)
- Dystonia and Tremor (2021) (8)
- Gabapentin enacarbil in subjects with moderate to severe primary restless legs syndrome with and without severe sleep disturbance: an integrated analysis of subjective and novel sleep endpoints from two studies (2013) (8)
- Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome. (2016) (8)
- Effect of tetrabenazine on computerized dynamic posturography in Huntington disease patients. (2012) (8)
- Basal ganglia neuronal discharge in primary and secondary dystonia. (2004) (7)
- Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs (2008) (7)
- Movements Mimicking Myoclonus Associated with Spinal Cord Pathology: Is this a “Pure Motor Restless Legs Syndrome” (2012) (7)
- Paraspinal muscle asymmetry in Parkinson's disease (2014) (7)
- A novel scale to assess psychosis in patients with parkinson's disease (2015) (7)
- Essential Tremor (2006) (6)
- Restless abdomen: a spectrum or a phenotype variant of restless legs syndrome? (2020) (6)
- Tremor Research Group Essential Tremor Rating Scale (TETRAS): Assessing Impact of Different Item Instructions and Procedures (2020) (6)
- Placebo response in Parkinson trials using patient diaries: sites do matter. (2007) (6)
- Non-VMAT2 inhibitor treatments for the treatment of tardive dyskinesia (2018) (6)
- A Multi‐center Genome‐wide Association Study of Cervical Dystonia (2021) (5)
- Task Specific Tremor Subsequently Developing into Parkinson's Disease: Case Series (2020) (5)
- Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study (2021) (5)
- Stereotypies as a manifestation of acute hyperglycemia without ketosis (2012) (5)
- Levodopa-induced dyskinesias in spinocerebellar ataxia type 2. (2010) (5)
- Deep brain stimulation (DBS) for severe restless legs syndrome: therapeutic and physiologic considerations. (2017) (5)
- Investigational Pharmacological Treatments for Parkinson's Disease (2003) (5)
- Effects of pallidotomy on gait and balance. (2001) (5)
- Dextromethorphan/quinidine for chorea: an open-label assessment. (2012) (5)
- Efficacy and tolerability of NUPLAZID™ (pimavanserin) in PD Psychosis: Analysis of an integrated Phase 3 placebo-controlled dataset (2016) (5)
- When to worry about headache. Head pain as a clue to intracranial disease. (1995) (5)
- Movement Disorders in Clinical Practice (2010) (5)
- Treatment of Restless Legs Syndrome and Periodic Limb Movements (2019) (4)
- Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease). (2016) (4)
- Consensus guidelines on the construct validity of rodent models of restless legs syndrome (2022) (4)
- IPX066, a mixed immediate/sustained-release levodopa preparation for Parkinson’s disease (2014) (4)
- Experience, competency, and education: Graduating neurology residents' experience with tPA. Authors' reply (2002) (4)
- Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Effect of Fixed-Dose Deutetrabenazine by Baseline Comorbidities (S56.006) (2017) (4)
- Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials (2015) (4)
- Deutetrabenazine Treatment Response by Concomitant Dopamine-Receptor Antagonists in the Phase III, Randomized, Double-Blind, Placebo-Controlled AIM-TD Trial in Tardive Dyskinesia (TD) (P2.016) (2017) (4)
- Effect of tetrabenazine use on restless legs syndrome. (2010) (4)
- THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial (2021) (4)
- Sleep problems in Parkinson’s disease patients (2011) (4)
- International validation of the first united non motor symptoms scale for Parkinson's disease. Results from the first pilot NMSS study (2006) (4)
- 45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study (2019) (3)
- Stroke-related restless legs syndrome: epidemiology, clinical characteristics, and pathophysiology. (2022) (3)
- ROPINIROLE AND RESTLESS LEGS SYNDROME. AUTHOR'S REPLY (1999) (3)
- Stereotactic Neurosurgery for Dystonia (2000) (3)
- MYSTICOL: A multisite, double-blind, randomized, placebo-controlled trial of rimabotulinumtoxinB for the treatment of sialorrhea in Parkinson’s disease (PD) and other neurological conditions (P3.026) (2017) (3)
- Inter-Rater Reliability of the Essential Tremor Rating Assessment Scale (TETRAS) (S32.004) (2012) (3)
- Sensory immobilization testing and polysomnogram testing are useful research tools for restless legs syndrome (2003) (2)
- Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-Label Extension Study (P4.075) (2018) (2)
- 134 Improvements in Clinical Global Impression of Change With Deutetrabenazine Treatment in Tardive Dyskinesia From the ARM-TD and AIM-TD Studies (2018) (2)
- Reply to Ray and Weeks: Linkage for Restless Legs Syndrome on Chromosome 9p Is Significant (2005) (2)
- Parkinson’s disease and restless legs syndrome (2009) (2)
- P2.150 Ropinirole prolonged release improves nocturnal symptoms in patients with advanced Parkinson's disease: an analysis of individual items on the PDSS (2009) (2)
- Standards Subcommittee of the American Academy of Neurology Practice Parameter: Therapies for essential tremor: Report of the Quality (2009) (2)
- Guidelines for the first-line treatment of RLS / WED , prevention and treatment of dopaminergic augmentation A combined task force of the IRLSSG , EURLSSG , and the RLS-Foundation (2015) (2)
- The Non Motor Staging of Parkinson's Disease: Results from an International Study (2009) (2)
- Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Efficacy, Safety, and Tolerability of Fixed-Dose Deutetrabenazine for the Treatment of Moderate to Severe Tardive Dyskinesia (TD) (S56.007) (2017) (2)
- Onabotulinum Toxin-A Injections for Nocturnal Bruxism: A Parallel, Double Blind, Placebo Controlled Polysomnographic Study (P05.006) (2012) (2)
- Apomorphine Improves Morning Akinesia in Parkinson’s Disease: Interim Analysis of the AM-IMPAKT Trial (P7.072) (2014) (2)
- Tremor rating scales and laboratory tools for assessing tremor (2022) (2)
- Minimal Clinically Important Improvement in IRLS Total Score in Patients with Restless Legs Syndrome: A Post Hoc Analysis from a 6-Month Placebo-Controlled US-Based Study with Rotigotine Transdermal System (P02.059) (2013) (2)
- Interesting complication of the Medtronic Activa RC impulse pulse generator (2012) (1)
- Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Improvements in Clinical Global Impression of Change (CGIC) with Deutetrabenazine Treatment in Moderate to Severe Tardive Dyskinesia (TD) (S56.004) (2017) (1)
- O040 Ambulatory monitoring of motor fluctuations in Parkinson's disease (2008) (1)
- International validation study of the first comprehensive unified Nonmotor Symptoms Scale (NMSS) for Parkinson's disease (PD) (2006) (1)
- W-L-104 SLEEP IMPROVEMENTWITH ROTIGOTINE TRANSDERMAL SYSTEM IN PATIENTS WITH MODERATE-TO-SEVERE IDIOPATHIC RESTLESS LEGS SYNDROME (RLS): RESULTS FROM TWO 6-MONTH PLACEBO-CONTROLLED TRIALS (2011) (1)
- Gait and balance disorders. (2003) (1)
- Determination of the Minimal Clinically Important Improvement in IRLS Total Score in Patients with Moderate to Severe Restless Legs Syndrome Treated with Rotigotine Transdermal System: A Post Hoc Analysis from a 6-Month Placebo-Controlled European Study (P02.056) (2013) (1)
- Restless legs syndrome and periodic limb movements in Parkinson’s disease (2015) (1)
- TETRAS Spirals and Handwriting Samples: Determination of Optimal Scoring Examples (2021) (1)
- Exploratory cross-over, trial of augmented RLS with the dopamine receptor 1/5 antagonist ecopipam D1/D5 antagonist ecopipam for augmented RLS (2020) (1)
- Tremor Research Group Essential Tremor Rating Scale (TETRAS): Assessing Impact of Different Item Instructions (P6.062) (2018) (1)
- Myobloc® (rimabotulinumtoxinB) in the treatment of adult sialorrhea (2018) (1)
- 46 Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-label Extension Study (2019) (1)
- Efficacy Result from a Phase 2, Double-Blind, Placebo-Controlled Study of CX-8998 a State-Dependent T-Type Calcium (Cav3) Channel Modulator in Essential Tremor Patients (T-CALM) (S4.008) (2019) (1)
- Characterization of Tau Association with Parkinson's Disease (2003) (0)
- Plecanatide for Constipation Associated With Parkinsonʼs Disease: A Case Series (2018) (0)
- Reply (2001) (0)
- Restless Legs Syndrome : Diagnosis and Treatment (2016) (0)
- Does the Use of Intraoperative Microelectrode Recording Influence the Final Location of Lead Implant in Deep Brain Stimulation in Parkinson’s Disease Patients? (P1.166) (2015) (0)
- xtensive spherical amyloid deposition of pituitary adenoma resenting as pituitary apoplexy ear (2008) (0)
- SNCA-Rep1 polymorphism correlates with susceptibility and iron deficiency in restless legs syndrome. (2020) (0)
- Pathophysiology, Associations and Consequences of Sleep-Related Movement Disorders (2008) (0)
- Differentiating nocturnal leg cramps and restless legs (2014) (0)
- Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder (2017) (0)
- Gait analysis is more sensitive than finger tapping or UPDRS motor scores in assessment of the motor response to levodopa in Parkinson's disease (2008) (0)
- Comprar Movement Disorders in Clinical Practice | Chaudhuri, K. Ray | 9781849960649 | Springer (2010) (0)
- DaTscan is a robust imaging modality for evaluation of patients with movement disorders (2012) (0)
- 158 Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study (2018) (0)
- Chapter 6 Secondary restless legs syndrome (2009) (0)
- A young man with a jerky hand (2008) (0)
- Chapter 8 Illustrative case reports (2009) (0)
- The Effect of Prior Exposure to Dopamine Agonists (DA) on Response to Treatment with Gabapentin Enacarbil (GEn) in Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome (RLS): Pooled Analyses from 3 Randomized Trials (P5.289) (2014) (0)
- Conversion of L-dopa to Extended Release L-dopa (Rytary®) in Patients with Fluctuating Parkinson's Disease: Predictors of Dose. (2019) (0)
- Appendix D: Practice parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidenced-based review): Report of the Quality Standards Subcommitte of the American Academy of Neurology (2007) (0)
- P3.182 Effect of tetrabenazine use in restless legs syndrome (2009) (0)
- The Efficacy of Gabapentin Enacarbil (GEn) in Adult Patients with Severe Primary Restless Legs Syndrome (RLS): Pooled Analyses From 3 Randomized Trials (I3-1.009) (2014) (0)
- Journal search and commentary Sensory immobilization testing and polysomnogram testing are useful research tools for restless legs syndrome q (2003) (0)
- 149 Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study (2018) (0)
- Reliability of the Clinician’s Tardive Inventory (CTI) (2023) (0)
- An international multicentre study validating the first screening questionnaire (NMS-quest) for comprehensive assessment of non motor symptoms of Parkinson's disease (2005) (0)
- Response to "Shaky legs: more than meets the eyes (or ears)". (2015) (0)
- Appendix H: Practice Parameter: Therapies for essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology (2007) (0)
- Deep brain stimulation in other neurological and psychiatric conditions (2015) (0)
- Tardive dyskinesia and pseudo-parkinsonism. In a nursing home patient who itched. (1993) (0)
- Book Review Psychogenic Movement Disorders: Neurology and Neuropsychiatry (Neurology Reference Series.) Edited by Mark Hallett, Stanley Fahn, Joseph Jankovic, Anthony E. Lang, C. Robert Cloninger, and Stuart C. Yudofsky. 353 pp., illustrated. Philadelphia, Lippincott Williams & Wilkins, 2006. $99. 0 (2006) (0)
- Facial Myokymia and Hemimasticatory Spasm with Linear Focal Alopecia (2022) (0)
- Reply (1999) (0)
- SLEEP IMPROVEMENT WITH ROTIGOTINE TRANSDERMAL SYSTEM IN PATIENTS WITH MODERATE-TO-SEVERE IDIOPATHIC RESTLESS LEGS SYNDROME (RLS): RESULTS FROM TWO 6-MONTH PLACEBO-CONTROLLED TRIALS (2011) (0)
- 0547 RLS Patient Odyssey Survey II (2022) (0)
- Predictive modeling of spread in adult‐onset isolated dystonia: Key properties and effect of tremor inclusion (2021) (0)
- AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions (2021) (0)
- Reply (1999) (0)
- Reliability of the Essential Tremor Rating Assessment Scale in Untrained Neurology Residents (S53.006) (2013) (0)
- In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome. (2018) (0)
- Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study (2021) (0)
- FP41-TH-06 Ambulatory monitoring of gait in Parkinson's disease (2009) (0)
- WHEN TO WORRY ABOUT HEADCHE : HEAD PAIN AS A DUE TO INTRACRANIAL DISEASE (1995) (0)
- Efficacy of apomorphine subcutaneous injections for the management of morning akinesia in Parkinson’s Disease (P1.189) (2015) (0)
- Restless legs syndrome. (2009) (0)
- Pramipexole: A viewpoint by William G. Ondo (2007) (0)
- PL4.2 Selected oral abstract: Objective measures of motor uctuations and freezing of gait in Parkinson's disease (2008) (0)
- International validation of the first non-motor questionnaire (NMSQuest) and scale (NMSS) for Parkinson's disease (2007) (0)
- Familial Corticobasal Syndrome Associated with Basal Ganglia Hypointensities (P06.081) (2012) (0)
- Clozapine: Efficacy for Parkinson Disease psychosis in patients refractory to pimavanserin. (2023) (0)
- Enhancing GABA inhibition is the next generation of medications for essential tremor. (2022) (0)
- Non-Motor Symptoms Questionnaire (2021) (0)
- The A11 Lesion/Iron Deprivation Animal Model of Restless Legs Syndrome (2015) (0)
- The Effect of Prior Exposure to Dopamine Agonists (DA) on Response to Treatment With Gabapentin Enacarbil in Adult Patients With Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analyses From 3 Randomized Trials (2014) (0)
- Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary? (2023) (0)
- Clinical research is the study of patients with diseases, disorders, syndromes, and maladies, studied to improve our collective understanding. In other words, scientists are looking for something. And hoping to find it. However, sometimes RLS finds you. (2012) (0)
- Overview of the Medical Treatments of Hyperkinetic Disorders (2012) (0)
- Restless Legs Syndrome in Neurological Disorders (2009) (0)
- Rasagiline preclinical studies: Implications for neuroprotection (2006) (0)
- The Brain’s Dopamine Systems and Their Relevance to Restless Legs Syndrome (2016) (0)
- A Multi-Center, Randomized, Controlled Trial of Unilateral Focused Ultrasound Thalamotomy for Essential Tremor (S27.004) (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William George Ondo?
William George Ondo is affiliated with the following schools:
